Do You Have Pancreatic Cancer?
You May Qualify for a Clinical Trial
You may qualify to participate in the TIGeR-PaC clinical trial.
A Phase III clinical trial called TIGeR-PaC is enrolling patients diagnosed with locally advanced pancreatic cancer.
The trial is comparing the use of a device to deliver chemotherapy locally through the artery near the tumor site as an investigational targeted treatment option vs. conventional delivery of systemic chemotherapy through the vein.
You May Qualify If You Have:
- Locally advanced pancreatic cancer diagnosis
- Are not a candidate for surgery
Drug-delivery system inserted into artery
Investigational targeted delivery of chemotherapy
Trial-related medical costs will be covered by your insurance or by the trial sponsor conducting the TIGeR-PaC Study. If you qualify to receive this investigational treatment, all trial-related medical care will be provided at no additional cost to you. Participation in the TIGeR-PaC trial is voluntary. If you qualify and choose to enroll, you can leave the trial at any time, for any reason.
Contact Us for More Information
Visit renovorx.com or clinicaltrials.gov for details on the TIGeR-PaC trial: https://clinicaltrials.gov/study/NCT03257033